1. Adelaide Research & Scholarship

Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 21-30 of 61 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2012Common variants at 6q22 and 17q21 are associated with intracranial volumeIkram, M.; Fornage, M.; Smith, A.; Seshadri, S.; Schmidt, R.; Debette, S.; Vrooman, H.; Sigurdsson, S.; Ropele, S.; Taal, H.; Mook-Kanamori, D.; Coker, L.; Longstreth Jr, W.; Niessen, W.; DeStefano, A.; Beiser, A.; Zijdenbos, A.; Struchalin, M.; Jack Jr, C.; Rivadeneira, F.; et al.
2013Salvage second hematopoietic cell transplantation in myelomaMichaelis, L.; Saad, A.; Zhong, X.; Le-Rademacher, J.; Freytes, C.; Marks, D.; Lazarus, H.; Bird, J.; Holmberg, L.; Kamble, R.; Kumar, S.; Lill, M.; Meehan, K.; Saber, W.; Schriber, J.; Tay, J.; Vogl, D.; Wirk, B.; Savani, B.; Gale, R.; et al.
2013PIK3CA and PTEN gene and exon mutation-specific clinicopathologic and molecular associations in colorectal cancerDay, F.; Jorissen, R.; Lipton, L.; Mouradov, D.; Sakthianandeswaren, A.; Christie, M.; Li, S.; Tsui, C.; Tie, J.; Desai, J.; Xu, Z.; Molloy, P.; Whitehall, V.; Leggett, B.; Jones, I.; McLaughlin, S.; Ward, R.; Hawkins, N.; Ruszkiewicz, A.; Moore, J.; et al.
2013Phase III randomized, placebo-controlled study of cetuximab plus brivanib alaninate versus cetuximab plus placebo in patients with metastatic, chemotherapy-refractory, wild-type K-RAS colorectal carcinoma: The NCIC clinical trials group and AGITG co.Siu, L.; Shapiro, J.; Jonker, D.; Karapetis, C.; Zalcberg, J.; Simes, J.; Couture, F.; Moore, M.; Price, T.; Siddiqui, J.; Nott, L.; Charpentier, D.; Liauw, W.; Sawyer, M.; Jefford, M.; Magoski, N.; Haydon, A.; Walters, I.; Ringash, J.; Tu, D.; et al.
2015Endovascular therapy for ischemic stroke with perfusion-imaging selectionCampbell, B.; Mitchell, P.; Kleinig, T.; Dewey, H.; Churilov, L.; Yassi, N.; Yan, B.; Dowling, R.; Parsons, M.; Oxley, T.; Wu, T.; Brooks, M.; Simpson, M.; Miteff, F.; Levi, C.; Krause, M.; Harrington, T.; Faulder, K.; Steinfort, B.; Priglinger, M.; et al.
2012Pemetrexed versus pemetrexed and carboplatin as second-line chemotherapy in advanced non-small-cell lung cancer: Results of the GOIRC 02-2006 randomized phase II study and pooled analysis with the NVALT7 trialArdizzoni, A.; Tiseo, M.; Boni, L.; Vincent, A.; Passalacqua, R.; Buti, S.; Amoroso, D.; Camerini, A.; Labianca, R.; Genestreti, G.; Boni, C.; Ciuffreda, L.; Di Costanzo, F.; De Marinis, F.; Crino, L.; Santo, A.; Pazzola, A.; Barbieri, F.; Zilembo, N.; Colantonio, I.; et al.
2011A novel recurrent mutation in MITF predisposes to familial and sporadic melanomaYokoyama, S.; Woods, S.; Boyle, G.; Aoude, L.; MacGregor, S.; Zismann, V.; Gartside, M.; Cust, A.; Haq, R.; Harland, M.; Taylor, J.; Duffy, D.; Holohan, K.; Dutton-Regester, K.; Palmer, J.; Bonazzi, V.; Stark, M.; Symmons, J.; Law, M.; Schmidt, C.; et al.
2014Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanomaAoude, L.; Pritchard, A.; Robles-Espinoza, C.; Wadt, K.; Harland, M.; Choi, J.; Gartside, M.; Quesada, V.; Johansson, P.; Palmer, J.; Ramsay, A.; Zhang, X.; Jones, K.; Symmons, J.; Holland, E.; Schmid, H.; Bonazzi, V.; Woods, S.; Dutton-Regester, K.; Stark, M.; et al.
2015Serum levels of human MIC-1/GDF15 vary in a diurnal pattern, do not display a profile suggestive of a satiety factor and are related to BMITsai, V.; Macia, L.; Feinle-Bisset, C.; Manandhar, R.; Astrup, A.; Raben, A.; Lorenzen, J.; Schmidt, P.; Wiklund, F.; Pedersen, N.; Campbell, L.; Kriketos, A.; Xu, A.; Zhou, P.; Jia, W.; Curmi, P.; Angstmann, C.; Lee-Ng, K.; Zhang, H.; Marquis, C.; et al.; Young, M.
2015Influence of light exposure during early life on the age of onset of bipolar disorderBauer, M.; Glenn, T.; Alda, M.; Andreassen, O.; Angelopoulos, E.; Ardau, R.; Baethge, C.; Bauer, R.; Baune, B.; Bellivier, F.; Belmaker, R.; Berk, M.; Bjella, T.; Bossini, L.; Bersudsky, Y.; Wo Cheung, E.; Conell, J.; Del Zompo, M.; Dodd, S.; Etain, B.; et al.

Discover